CardioFocus
PrivateLast Round
Series E
Feb 24, 2023
Total Funding Raised
$221.51M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CardioFocus operates in Healthcare & Life Sciences and is based in Marlborough, Massachusetts. Its latest recorded funding round was a Series E round in February 2023.
CardioFocus is a medical device company that specializes in innovative solutions for the precise treatment of atrial fibrillation through a comprehensive system of advanced devices, including a balloon catheter, endoscope, deflectable sheath, and integrated console.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CardioFocus Comparables
Compare CardioFocus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kardium | 86% | |
| Field Medical | 86% | |
| Adagio Medical | 81% |
For institutional investors. Book with your work email.
CardioFocus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Feb 24, 2023 | ||||
| Series E | Apr 12, 2022 | ||||
| VC Round | Jul 7, 2020 | ||||
| Private Placement | Apr 28, 2020 | ||||
| Series E | May 28, 2019 | ||||
Debt | Jun 22, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CardioFocus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kennedy Lewis Investment Management | Private Placement, Series E, VC Round |
| Manatuck Hill Partners | Private Placement, VC Round |
| SV Health Investors | Private Placement, Series E, VC Round, Series C, Series B |
| Fletcher Spaght | Private Placement |
| Accuitive Medical Ventures | Private Placement, Series E, VC Round, Series C |
| Kestrel Venture Management | Private Placement, VC Round, Series B |
| Fletcher Spaght Ventures | Private Placement, Series E, VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 39% MoM, reaching 2K.
- Feb 3, 2026
Expanded Pulsed Field Ablation (PFA) clinical programs.
For institutional investors. Book with your work email.
CardioFocus Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CardioFocus's valuation, stock price, and market status.
Is CardioFocus a public or private company?
CardioFocus is a private company.
What is the current stock price of CardioFocus?
CardioFocus is a private company, so its shares have no public market price. Caplight tracks CardioFocus's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CardioFocus worth (valuation)?
Valuation information for CardioFocus is not publicly available.
Can I buy CardioFocus stock?
CardioFocus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CardioFocus's last funding round?
CardioFocus's most recent funding round was Series E on February 24, 2023.
Who are the main investors in CardioFocus?
Key investors in CardioFocus include SV Health Investors, KBL Healthcare Ventures, H.I.G. Capital.
Will CardioFocus IPO soon?
No public IPO plans have been announced for CardioFocus.
How can I track CardioFocus secondary market activity?
Caplight tracks bids, offers, and trades in CardioFocus's shares on secondary markets.